Sign In
Buy DGX
$193.67
+0.510 (+0.264%)
At Close: Jun 03, 2026
Quest Diagnostics (NYSE:DGX) Issues Q2 2020 Pre-Market Earnings Guidance
07:12am, Monday, 13'th Jul 2020
Quest Diagnostics (NYSE:DGX) issued an update on its second quarter 2020 Pre-Market earnings guidance on Monday morning. The company provided earnings per share guidance of 1.39-1.42 for the period, c
Wedge Capital Management L L P NC Has $771,000 Stake in Quest Diagnostics Inc (NYSE:DGX)
06:32am, Monday, 13'th Jul 2020
Wedge Capital Management L L P NC decreased its position in shares of Quest Diagnostics Inc (NYSE:DGX) by 22.9% in the second quarter, according to the company in its most recent 13F filing with the S
Baxter Gets FDA Nod for Altapore Shape Bioactive Bone Graft
12:00am, Friday, 10'th Jul 2020
Stocks Analysis by Zacks Investment Research covering: Baxter International Inc, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, West Pharmaceutical Services Inc. Read Zack
LabCorp Launches At-Home Coronavirus Test Collection Kit
12:48pm, Wednesday, 08'th Jul 2020
LabCorp (LH) claims this to be the first digital COVID-19 service that physicians can use to remotely diagnose patients before any surgery or procedure.
BD Receives EUA for New Antigen Test to Combat COVID-19
12:41pm, Wednesday, 08'th Jul 2020
Becton, Dickinson (BDX) receives EUA from the FDA for a rapid, point-of-care, antigen test to detect SARS-CoV-2 in 15 minutes.
BD Unveils BD PurPrep Patient Preoperative Skin Preparation
12:39pm, Wednesday, 08'th Jul 2020
By developing fully sterile PurPrep, BD (BDX) is offering health care experts a more complete set of tools to mitigate the risk of intrinsic contamination in antiseptic solutions.
5 Stocks With Relative Price Strength to Enhance Your Returns
12:02pm, Wednesday, 08'th Jul 2020
Want to try an out-of-the-box approach to earn handsome returns? Tap these stocks with explosive relative price strength.
HPV Test Misses Twice as Many Women Who Develop Cervical Cancer as Cotesting, Quest Diagnostics Health Trends™ Study Finds
11:03am, Wednesday, 08'th Jul 2020
A Health Trends™ study from researchers at Quest Diagnostics (NYSE: DGX) and the University of Pittsburgh Medical Center (UPMC) provides new evidence that the HPV screening test is significantly les
Myriad Genetics, OptraHEALTH Partner to Offer Cancer Knowledge
10:32pm, Tuesday, 07'th Jul 2020
Myriad Genetics (MYGN) collaborates with OptraHEALTH to provide an AI-powered cognitive ChatBOT to serve as a genetic health knowledge platform to prospective hereditary cancer patients.
Outlook for Diagnostics Sector Tests Positive
03:26pm, Tuesday, 07'th Jul 2020
The Covid-19 crisis has been very good to companies making tests and that isn’t likely to disappear once the current wave of infections does.
Align Technology's Rollouts Aid Amid Procedural Deferrals
02:24pm, Tuesday, 07'th Jul 2020
Align Technology's (ALGN) new virtual solutions ensure continuity of care amid pandemic.
Thermo Fisher Stock Rises on Solid Q2 Growth Expectation
02:21pm, Tuesday, 07'th Jul 2020
Thermo Fisher (TMO) provides encouraging Q2 guidance for organic growth.
Dividend Changes: June 27-July 3, 2020
01:30pm, Tuesday, 07'th Jul 2020
This article series provides a weekly summary of dividend changes, including dividend increases and dividend cuts or suspensions.
Myriad Genetics, OptraHEALTH Partner to Offer Cancer Knowledge
12:00am, Tuesday, 07'th Jul 2020
Stocks Analysis by Zacks Investment Research covering: Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Myriad Genetics Inc. Read Zacks Investment Research's latest article
